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Aminoglycosides Apramycin, gentamycin, hygromycin B, 
kanamycin, neomycin, paromomycin, 
tobramycin
Elongation (translocation) Most aminoglycoside antibiotics induce translational misreading by promoting 
binding of near-cognate tRNAs, but the biological effect is probably due to inhibition 
of the translocation reaction and promotion of back-translocation.
Edeine Edeine A Initiation (fMet-tRNA 
binding) 
Edeine prevents binding of the initiator tRNA to the 30S subunit in an mRNA-
dependent manner.
GE81112 GE81112 Initiation (fMet-tRNA 
binding) 
GE81112 inhibits binding of the initiator tRNA to the 30S subunit in an mRNA-
independent manner.
Kasugamycin Kasugamycin Initiation (fMet-tRNA 
binding) 
Kasugamycin inhibits translation initiation of canonical mRNAs by binding in the 
path of the mRNA and preventing stable interaction of the initiator tRNA with the 
start codon. 
Pactamycin Pactamycin Initiation, elongation 
(translocation) 
Early data suggest that pactamycin allows 30S but not 70S initiation complex 
formation, whereas recently pactamycin was shown to inhibit translocation in a 
tRNA-mRNA-dependent manner.
Spectinomycin Spectinomycin Elongation (translocation) Spectinomycin binds to the neck of the small subunit and prevents the relative 
movement of the head and body that is needed for the completion of translocation. 
Streptomycin Streptomycin Elongation (misreading) Streptomycin increases affinity of tRNA for the A site, has a modest inhibitory effect 
on translocation, promotes back-translocation, and induces high-level translational 
misreading.
Tetracyclines/glycylcyclines Doxycycline, minocycline, tetracycline/
tigecycline
Elongation (tRNA delivery) Tetracyclines prevent stable binding of the EF-Tu-tRNA-GTP ternary complex to 
the ribosome and inhibit accommodation of A-tRNAs upon EF-Tu-dependent GTP 
hydrolysis.
Viomycin Capreomycin, viomycin Elongation (translocation) Viomycin locks tRNAs in a hybrid-site translocation intermediate state, preventing 
conversion by EF-G into a posttranslocation state.
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Blasticidins Blasticidin S Elongation 
(peptidyltransferase) 
Two molecules of Blasticidin S mimic the C74 and C75 of P-tRNA and in doing 
so inhibit peptide bond formation by preventing tRNA binding at the P site of the 
peptidyltransferase center (PTC).
Chloramphenicols Chloramphenicol Elongation 
(peptidyltransferase) 
Chloramphenicol binds at the A site of the PTC where it perturbs placement of A 
site tRNA and thus prevents peptide bond formation.
Hygromycin A Hygromycin A Elongation 
(peptidyltransferase) 
Hygromycin A overlaps in its binding site with chloramphenicol and inhibits peptide 
bond formation by inhibiting the placement of the A site tRNA at the PTC.
Ketolides Cethromycin (ABT-773), telithromycin Elongation (nascent chain 
egress)  
Ketolides are derivatives of macrolides where the ketone group replaces the C3 
sugar. Ketolides exhibit the same mechanism of action as macrolides by blocking 
the ribosomal tunnel and inducing peptidyl-tRNA drop-off.
Lincosamides Clindamycin, lincomycin Elongation 
(peptidyltransferase) 
Lincosamides span across both A and P sites of the PTC and inhibit binding of 
tRNA substrates at both these sites.
Macrolides Azithromycin, carbomycin A, 
clarithromycin, erythromycin, 
spiramycin, troleandomycin, tylosin
Elongation (nascent chain 
egress) 
Macrolides bind within the ribosomal tunnel and prevent elongation of the nascent 
polypeptide chain, which leads to peptidyl-tRNA drop-off. Some macrolides, such 
as carbomycin A and tylosin, also directly inhibit peptide bond formation.
Orthosomycins Avilamycin, evernimicin Initiation (70S-IC formation) Orthosomycins interact with the large subunit and prevent the joining of the 30S-IC 
with the large subunit to form the 70S-IC in an IF2-dependent manner.
Oxazolidinones Eperezolid, linezolid Elongation 
(peptidyltransferase) 
Linezolid binds at the PTC in a position overlapping the aminoacyl moiety of 
A-tRNA, preventing tRNA accommodation and peptide bond formation.
Puromycin Puromycin Elongation 
(peptidyltransferase) 
Puromycin is a structural analog of the 3′ end of a tRNA, which binds at the A site of 
the PTC and triggers premature release of the nascent polypeptide chain.
Ribotoxins α-sarcin Elongation (translocation), 
recycling 
α-sarcin cleaves the E. coli 23S rRNA on the 3′ side of G2661, abolishing the 
ribosome’s ability to stimulate the GTP hydrolysis activity of translation factors, 
such as EF-G.
Sparsomycin Sparsomycin Elongation 
(peptidyltransferase) 
Sparsomycin binds at the PTC where it blocks tRNA binding at the A site, while 
promoting translocation and stabilization of tRNA at the P site.
Streptogramins A/B Dalfopristin/quinupristin, virginiamycin 
M/S
Elongation 
(peptidyltransferase) 
Streptogramins A and B act synergistically to inhibit translation. SA compounds 
bind at the PTC overlapping A and P sites, whereas SB compounds bind within the 
tunnel in a similar location to macrolides.
Thiopeptides Micrococcin, nocathiacin, nosiheptide, 
thiazomycin, thiostrepton
Elongation (translocation), 
Recycling 
Thiopeptide antibiotics inhibit translocation by blocking the stable binding of EF-G 
to the ribosome. Thiopeptides also inhibit the action of translational GTPases, such 
IF2 and EF-Tu.
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Fusidic acid Fusidic acid Elongation (translocation) Fusidic acid stabilizes EF-G on the ribosome by allowing binding and GTP 
hydrolysis, but not Pi release, nor the associated conformational changes in EF-G 
necessary for dissociation.
GE2270A-like thiopeptides Amythiamicins, GE2270A, thiomuracins Elongation (tRNA delivery) The GE2270A-like thiopeptides, like pulvomycin, prevent ternary complex formation 
by binding to EF-Tu and blocking interaction of EF-Tu with aminoacyl-tRNAs. 
GE2270A and pulvomycin have distinct but overlapping binding sites on EF-Tu.
Kirromycins and enacyloxins Aurodox, kirromycin, and enacyloxin IIa Elongation (tRNA delivery) These drugs trap EF-Tu on the ribosome by allowing GTP hydrolysis but preventing 
Pi release and the conformational changes in EF-Tu that are necessary for tRNA 
release and EF-Tu dissociation.
Pulvomycin Pulvomycin Elongation (tRNA delivery) Pulvomycin prevents ternary complex formation by binding to EF-Tu and blocking 
interaction of EF-Tu with aminoacyl-tRNAs.
The translational apparatus is one of the major targets for antibiotics in the bacterial cell. Antibiotics predominantly interact with the functional centers of the ribosome, namely 
the messenger RNA (mRNA)-transfer RNA (tRNA) decoding region on the 30S subunit, the peptidyltransferase center on the 50S subunit, or the ribosomal exit tunnel through 
which the nascent polypeptide chain passes during translation. Protein synthesis can be divided into three phases: initiation, elongation, and termination/recycling.
1. Initiation
Translation initiation operates through a 30S initiation complex (30S-IC), consisting of the 30S, mRNA, initiator fMet-tRNA, and three initiation factors, IF1, IF2, and IF3. Sub-
sequently, the 30S-IC associates with the 50S, which releases the initiation factors (IFs) and leaves the initiator-tRNA at the peptidyl-tRNA-binding site (P site), base-paired to 
the start codon of the mRNA. The antibiotics edeine, GE81112, and kasugamycin interfere with 30S-IC assembly, whereas formation of a functional 70S-IC is blocked by the 
orthosomycins and pactamycins.
2. Elongation
The elongation phase involves the movement of tRNAs in a cyclic fashion through the three tRNA-binding sites (A→P→E) on the ribosome. The first step in the cycle involves 
the delivery of the aminoacyl-tRNA (aa-tRNA) to the aa-tRNA-binding site (A site), which is facilitated by the elongation factor EF-Tu•GTP. Hydrolysis of GTP by EF-Tu leads to 
its dissociation from the ribosome, allowing aa-tRNA accommodation. Peptide-bond formation then proceeds, transferring the entire polypeptide chain from the P-tRNA to the 
aa-tRNA in the A site. The ribosome now has a peptidyl-tRNA at the A site and an uncharged tRNA at the P site. This ribosomal state is highly dynamic with the tRNAs oscil-
lating between classical (A and P sites) and hybrid states (A/P and P/E sites on 30S/50S). EF-G binds to the ribosome, which stabilizes the tRNAs in hybrid states, hydrolyzes 
GTP to GDP, and catalyzes the translocation reaction. Translocation shifts the peptidyl-tRNA from the A/P hybrid state to the P site and the deacylated tRNA from the P/E to the 
exit site (E site). EF-G•GDP dissociates leaving the A site vacant for the next incoming aa-tRNA. The majority of antibiotics targeting translation inhibit a step associated with 
the elongation phase. Most antibiotics binding to the 30S perturb either tRNA binding, decoding, or translocation, whereas antibiotics targeting the 50S inhibit peptide-bond 
formation, extension of the polypeptide chain, or stable binding of translation factors. In contrast, some antibiotics interact directly with elongation factors and prevent them 
from dissociating from the ribosome.
3. Termination/Recycling
Arrival of an mRNA stop codon in the A site of the ribosome signals the termination of protein synthesis. Release factor 1 (RF1) or RF2 binds to the ribosome and hydrolyzes 
the peptidyl-tRNA bond, releasing the translated polypeptide chain from the ribosome. RF1/2 is recycled from the ribosome by RF3 in a GTP-dependent fashion. The ribosome 
is then split into subunits by the concerted action of EF-G and ribosome recycling factor (RRF), thus recycling the components for the next round of translation. There are no 
antibiotics that specifically inhibit termination and ribosome recycling; however antibiotics that target EF-G, such as α-sarcin, fusidic acid, and thiopeptides, also inhibit ribo-
some recycling.
Abbreviations
30S, small ribosomal subunit; 50S, large ribosomal subunit; aa-tRNA, aminoacyl-tRNA; A site, aa-tRNA-binding site; E site, exit site for tRNA; EF, elongation factor; IF, initiation 
factor; mRNA, messenger RNA; P-tRNA, peptidyl-tRNA; P site, P-tRNA-binding site; PTC, peptidyltransferase center; RRF, ribosome recycling factor; RF, release factor; tRNA, 
transfer RNA.
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